RenovoRx
RNXT
33 hedge funds and large institutions have $6.83M invested in RenovoRx in 2025 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
6% more funds holding
Funds holding: 31 → 33 (+2)
1.51% less ownership
Funds ownership: 19.45% → 17.94% (-1.5%)
52% less capital inflows, than outflows
Capital inflows: $778K | Capital outflows: $1.61M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealthspire Advisors (New York)
New York
|
+$253K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$219K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$90.1K |
| 4 |
Caprock Group
Boise,
Idaho
|
+$64K |
| 5 |
Bleichroeder LP
New York
|
+$61.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$1.1M |
| 2 |
Renaissance Technologies
New York
|
-$196K |
| 3 |
Corsair Capital Management
New York
|
-$119K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$68K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$62.5K |
RNXT Hedge Fund Activity: Q4 2025 in Review
33 of the 8,297 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q4 2025, worth a combined $6.83M — down 24% from $9.04M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RNXT positions and 6 closed out — a net gain of 2 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Wealthspire Advisors (New York), opening a new position worth an estimated $253K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.1M sold.
- 33 institutional investors held RenovoRx (RNXT) as of Q4 2025, up from 31 in Q3 2025.
- Funds reported $6.83M of RenovoRx stock for Q4 2025, down 24% quarter-over-quarter.
- 8 funds opened new RenovoRx positions in Q4 2025 and 6 closed out, a net change of +2 holders.
- The largest RenovoRx buyer in Q4 2025 was Wealthspire Advisors (New York), an estimated $253K added.
- The largest RenovoRx seller in Q4 2025 was AWM Investment Company, an estimated $1.1M sold.
Based on aggregated 13F filings for Q4 2025.